Uncategorized - December 4, 2014
Study: No Link Between Antibiotics, Asthma
According to a new register study in the scientific journal BMJ, researchers at Karolinska Institutet are able to dismiss previous claims that there is a link between the increased use of antibiotics in society and a coinciding rise in childhood asthma. The study includes half a million children and shows that exposure to antibiotics during pregnancy or […]
Companies - December 4, 2014
Relaxbirth Expanding to U.S., Gulf
Finnish medtech company Relaxbirth, which has developed a device to make the experience of childbirth better and quicker, is expanding to the U.S. and the Gulf. A pilot project at the Summa Akron City Hospital in Ohio is yielding positive feedback while participation in the Global Access program of the UCLA Anderson Business School, where final […]
Pharma Business - December 4, 2014
Pay-to-Delay Could Cost AZ Billions
AstraZeneca potentially could face billions of dollars in damages if it loses its “pay-to-delay” case currently in US. federal court in Boston. The case involves a 2008 settlement AstraZeneca reached with India’s Ranbaxy Laboratories to hold off on bringing to market a generic of its heartburn medication Nexium. The plaintiffs, which represent pharmacies, wholesalers and consumers, contend […]
Funding - December 3, 2014
Oslo Cancer Cluster Names Research Grant Winners
Oslo Cancer Cluster recently named three winners in a competition seeking collaborative projects involving immuno-oncology. The three, BerGen Bio, Targovax and Ultimovacs each will receive MNOK 0,4 from Innovation Norway. BerGenBio will use the award to prove that Axl kinase inhibition may provoke an anti-tumor immune response, working with partners from the University of Bergen, Oslo, […]
Clinical Trials - December 2, 2014
Ascendis Fundraising for Trial
Danish biotech Ascendis Pharma has put together a $60 million D round, cash that will help get its once-a-week treatment for growth hormone deficiency (GHD) into late-stage testing. Ascendis is relying on a technology called TransCon, a hydrogel made of prodrug linkers that seek out targeted molecules in the body and then release their dosage.The […]
Uncategorized - December 2, 2014
Selenium Slows Hyper-Response to Cancer
Researchers from the University of Copenhagen have demonstrated that selenium – naturally found in garlic and broccoli – slows down the body’s over-response to certain cancers that leaves patients feeling weak. The findings, which could improve cancer treatment, have been published in the Journal of Biological Chemistry. Cells undergoing change, such as precursors of cancer […]
